Your browser doesn't support javascript.
Response to: 'Hydroxychloroquine ineffective for COVID-19 prophylaxis in lupus and rheumatoid arthritis' by Singer et al.
Ugarte-Gil, Manuel Francisco; Konig, Maximilian F; Korsten, Peter; Berenbaum, Francis; Kim, Alfred Hyoungju; Sparks, Jeffrey A.
  • Ugarte-Gil MF; Department of Rheumatology, Universidad Cientifica del Sur, Lima, Peru.
  • Konig MF; Division of Rheumatology, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA.
  • Korsten P; Department of Nephrology and Rheumatology, University Medical Center Göttingen, Gottingen, Germany.
  • Berenbaum F; Rheumatology, Sorbonne Université, Paris, France.
  • Kim AH; Medicine/Rheumatology, Washington University in Saint Louis School of Medicine, St. Louis, Missouri, USA jsparks@bwh.harvard.edu akim@wustl.edu.
  • Sparks JA; Department of Medicine, Division of Rheumatology, Inflammation, and Immunity, Brigham and Women's Hospital, Boston, Massachusetts, USA jsparks@bwh.harvard.edu akim@wustl.edu.
Ann Rheum Dis ; 2020 Aug 05.
Article in English | MEDLINE | ID: covidwho-696841
Keywords
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: Available Collection: International databases Database: MEDLINE Language: English Year: 2020 Document Type: Article Affiliation country: Annrheumdis-2020-218683

Similar

MEDLINE
LILACS
LIS
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: Available Collection: International databases Database: MEDLINE Language: English Year: 2020 Document Type: Article Affiliation country: Annrheumdis-2020-218683